drugset / Trial / NCT02406872
A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in Operations
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to find out the optimal dose for Remimazolam Tosilate as an intravenous general anaesthetic drug in operations and to determine its efficacy and safety profile comparing to propofol.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | 2 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | 2.5 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 6 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 12 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 18 mg/kg | Intravenous |
Indications
No indication recorded.